The total return over the past 12 months is -78.27% vs. +16.94% for the S&P 500. So far it's up -66.82% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (78.27%) | (54.01%) | (67.75%) | N/A | N/A | N/A |
| Total Return CAGR | (78.27%) | (54.01%) | (67.75%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | (75.06%) | (43.85%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Senti Biosciences, Inc. (SNTI)
| Year | Start price | End price | SNTI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.04 | $0.35 | (66.82%) | +14.51% | (81.33%) |
| 2025 | $3.51 | $1.04 | (70.37%) | +17.72% | (88.09%) |
| 2024 | $6.60 | $3.51 | (46.82%) | +24.89% | (71.71%) |
| 2023 | $14.10 | $6.60 | (53.19%) | +26.19% | (79.38%) |
| 2022 | $98.60 | $14.10 | (85.70%) | (18.17%) | (67.53%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
